[Bromocriptine in patients with idiopathic edema (author's transl)].
The diuretic therapy of patients with idiopathic edema is known to induce a secondary aldosteronism, which perpetuates edema formation and exacerbates the clinical symptoms. The observation of a decreased excretion of dopamine in these patients suggests that a treatment with the orally active dopamine agonist bromocriptine might be beneficial. Nine patients with typical symptoms of idiopathic edema, which had been present for several years, were treated with bromocriptine (Pravidel) 2 X 2.5 mg/die. The response to therapy was assessed clinically by the normalization of diurnal weight gain and general well-being. Seven patients showed a good response to bromocriptine, in one patient the response was only modest, and in one patient the medication had to be stopped because of nausea. Bromocriptine normalized diurnal weight gain without inducing weight loss. Both without therapy and during bromocriptine treatment electrolytes in serum, blood pressure, plasma renin activity and aldosterone are within the normal range. From the present pilot study it can be concluded that bromocriptine is an effective alternative to the traditional diuretic therapy in some patients with idiopathic edema. It remains unclear, whether the beneficial effect of bromocriptine reveals a dopamine deficiency, or whether bromocriptine is only a symptomatic treatment.
D000328:Adult; D000450:Aldosterone / Q000097:blood; D001835:Body Weight / Q000187:drug effects; D001971:Bromocriptine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004487:Edema / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged
D001971:Bromocriptine; D000450:Aldosterone
Uber die Behandlung idiopathischer Odeme mit Bromocriptin (author's transl)]